Two FDA websites and three FDA guidance documents regarding DMFs
21 CFR Part 314 Applications for FDA approval to market a new drug, Subpart G- Miscellaneous Provisions, Section 314.420 Drug master files
Drug Master Files (DMFs)
Guidance for Industry: Drug Master Files for Bulk Antibiotic Drug Substances
Drug Master Files: Guidelines
Draft Guidance for Industry: Submitting Type V Drug Master Files to the Center for Biologics Evaluation and Research
When the DMF should be filed with the FDA
Information to be contained in the DMF
Checklist to construct a DMF from scratch
Experiences of others regarding real world issues associated with creating and submitting DMFs
Who should Attend
Attendees from Regulatory Affairs, Manufacturing, Quality Assurance & Control, Research and Development, Development and Preparation of Submission Materials and Validation.
Past Events
Drug Master Files (DMF) - Translating FDA Guidances into usable documentation 2019 - 18-19 Jul 2019, San Diego, California, United States (34593)
Drug Master Files (DMF) - Translating FDA Guidances into usable documentation 2026
Important
Please, check "Drug Master Files (DMF) - Translating FDA Guidances into usable documentation" official website for possible changes, before making any traveling arrangements